Agriculture
November 9, 2023
Updated on November 9, 2023
·Created on August 31, 2021
Monitors and detects changes in pulmonary gas exchange in diseased states. Courtesy of WHO Compendium 2021
The MediPines AGM100 provides real-time measurements of 12 respiratory metrics by sampling a patient’s normal breathing and can be used to detect respiratory impairments such as those resulting from COVID-19. The device is non-invasive, portable, and displays all respiratory measurements in one output screen.
This product was selected for inclusion in WHO’s 2021 Compendium of Innovative Health Technologies for Low‐Resource Settings.
Target Users (Target Impact Group)
Distributors / Implementing Organizations
This product is available from the manufacturer.
Manufacturing/Building Method
Manufactured in the United States
Intellectural Property Type
Patent Protected
User Provision Model
Users can obtain the product directly from the manufacturer.
Distributions to Date Status
As of October 2020, between 0-100 units have been distributed.
Design Specifications
While wearing a pulse oximeter and nose clip, the patient breathes normally through a provided breathing circuit. Over the course of the 2-minute test, the monitor will display either real-time breathing gas waveforms or clinical parameters. After the test, the results can be saved or printed. The device is portable and can utilize its internal rechargeable battery when not connected to a direct power source. The backup battery can provide up to 2 hours of power at full charge, and takes 4 hours to fully recharge the battery. The device weighs ~ 1.7 kg.
Technical Support
Provided by the manufacturer.
Replacement Components
The oxygen sensor is available on the open market and can also be purchased through MediPines.
Lifecycle
0-2 year lifetime, includes a 1-year warranty
Manufacturer Specified Performance Parameters
The manufacturer specified performance targets include automatic calibration, high accuracy, 1-2 minute reading turnaround, non-invasive, push-button operation, portable, economical, and efficient.
Vetted Performance Status
Testing performed by academic institutions found that the device "provided a valid and reliable measure against directly measured arterial blood gasses at rest and during hypoxic exercise". Another study found that this device is "very sensitive to the presence of disease and may discard the need for arterial punctures in many instances" for patients with lung disease. Additionally, this device has been tested for water ingress/mechanical strength testing, Electrical Safety testing (60601-1-2), and Medical Device Safety Standards Testing (60601-1, 80601-2-55, 80601-2-61).
Safety
The device should be operated by a trained individual with appropriate decontamination between use.
Complementary Technical Systems
SpO2 sensor, MediPines Single Patient Use Breathing Circuit Kit, Noseclip, and power source for charging the battery/use.
Academic Research and References
Howe, C., et. al, 2020, Validation of a Non-invasive Assessment of Pulmonary Gas Exchange During Exercise in Hypoxia. Chest, Vol. 158(4), pp. 1644-1650.
West J.B., et. al, 2018, A New, Noninvasive Method of Measuring Impaired Pulmonary Gas Exchange in Lung Disease: An Outpatient Study. Chest. Vol. 154(2), pp. 363-369.
Compliance with regulations
AAMI / ANSI ES60601-1:2005/ (R)2012 + A1:2012 + C1:2009/(R)2012 + A2:2010/(R)2012 IEC 60601-1-2:2014 ISO 80601-2-61: 2011 ISO 80601-2-55:2011 IEC 62304: 2006 IEC 60068-2-27:2008 IEC 60068-2-64:2008 ISO 10993-1:2009/(R)2013 ISO 10993-5:2009 ISO 10993-10:2010 ISO 14971:2007
Other Information
None
Agriculture
November 9, 2023
Agriculture
November 9, 2023
Agriculture
November 9, 2023
Agriculture
November 9, 2023
Agriculture
November 9, 2023
Agriculture
November 9, 2023
Agriculture
November 9, 2023
Agriculture
November 9, 2023
Agriculture
November 9, 2023
Implemented by
Puralytics
Agriculture
November 9, 2023
Have thoughts on how we can improve?
Give Us Feedback